Nsi Retail Advisors, LLC Eli Lilly & CO Transaction History

Nsi Retail Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $118,440 - $158,456	-200 Reduced 26.42%	557 $433,000
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $369,495 - $509,404	-850 Reduced 52.89%	757 $407,000
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $350,740 - $468,980	-1,000 Reduced 38.36%	1,607 $754,000
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $177,888 - $202,722	-600 Reduced 18.71%	2,607 $843,000
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $278,730 - $327,270	-1,000 Reduced 23.77%	3,207 $1.04 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $66,480 - $81,813	-300 Reduced 6.66%	4,207 $972,000
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $54,165 - $70,062	300 Added 7.13%	4,507 $1.03 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $759,573 - $982,502	4,207 New	4,207 $966,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Nsi Retail Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nsi Retail Advisors, LLC with notifications on news.